DEF 14A: Definitive Healthcare Corp. Announces 2024 Annual Meeting of Stockholders

Definitive Healthcare Corp. will hold its 2024 Annual Meeting of Stockholders on May 22, 2024, to vote on director elections, auditor ratification, and executive compensation.

Summary

• Definitive Healthcare Corp. is holding its Annual Meeting of Stockholders on May 22, 2024, at 3:00 PM Eastern Time, in Framingham, MA.
• Stockholders of record as of March 25, 2024, are eligible to vote.
• The meeting will address the election of three Class III directors (Jeff Haywood, Scott Stephenson, and Kathleen A. Winters) for a three-year term expiring in 2027.
• Stockholders will also vote to ratify the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024.
• An advisory vote on the compensation of the company's Named Executive Officers (NEOs) will also take place.
• The Board of Directors recommends voting FOR the election of the director nominees, FOR the ratification of Deloitte & Touche LLP, and FOR the advisory vote on executive compensation.
• The company's Class A common stock and Class B common stock will vote together as a single class on all matters.
• In 2023, Definitive Healthcare Corp. delivered a 13% year-over-year revenue growth rate, a (115)% net loss margin, and a 30% adjusted EBITDA margin.

Sentiment

Score: 6

Explanation: The document presents a mixed sentiment. While there's revenue growth and adjusted EBITDA profitability, the significant net loss and goodwill impairment temper the overall outlook. The company's strategic positioning and long-term potential are highlighted, but the current financial performance raises concerns.

Positives

• The Board of Directors is actively engaged in overseeing the company's strategic plans and risks related to sustainability, environmental, social, and governance matters (ESG).
• The company has implemented stock ownership guidelines for executives and non-employee directors to align their interests with those of stockholders.
• The company has a clawback policy in place to recover erroneously awarded performance-based compensation from executive officers in the event of an accounting restatement.
• The company prohibits directors, officers, and employees from hedging or pledging company securities.
• The company's compensation policies and practices are designed to attract and retain talented and experienced executives.

Negatives

• The company reported a GAAP Net loss inclusive of a $287.4 million goodwill impairment charge of $(289.6) million, or (115)% of revenue, for the full year 2023.
• The company's stock price has experienced a sustained decline, which triggered a goodwill impairment test as of September 30, 2023.
• The company's annual recurring revenue (ARR) growth rate was 6% from year-end 2022 to year-end 2023, which may be considered low by some investors.

Risks

• The company's future performance is subject to various risks, including macroeconomic conditions, competition, and regulatory changes.
• The company's ability to retain and attract key personnel is critical to its success.
• The company's compensation policies and practices could potentially lead to excessive risk-taking behavior.
• The company's reliance on a few key customers could expose it to financial risk if those customers were to reduce their spending or terminate their contracts.
• The company's ability to successfully integrate acquired businesses is uncertain.

Future Outlook

The company believes it is well positioned for the long term with a leadership position in a large and attractive market, supporting predictable revenue growth, adjusted EBITDA profitability, and capital efficiency.

Management Comments

• At Definitive Healthcare, our mission is to transform data, analytics, and expertise into healthcare commercial intelligence.
• We help clients uncover the right markets, opportunities, and people, so our customers can shape tomorrows healthcare industry.
• Our SaaS platform creates new paths to commercial success in the healthcare market, so companies can identify where to go next.

Industry Context

This announcement reflects the ongoing corporate governance activities typical of publicly traded companies, including the election of directors, ratification of auditors, and advisory votes on executive compensation. The financial results highlight the company's growth and profitability in the healthcare commercial intelligence market.

Comparison to Industry Standards

• The document mentions a peer group of companies used for compensation benchmarking, including Amplitude, Braze, Veeva Systems, and ZoomInfo Technologies.
• These companies operate in the health care technology, application software, and interactive media and services industries.
• The document does not provide a direct comparison of Definitive Healthcare's financial performance to these peers, but it suggests that the company aims to maintain competitive compensation practices.

Management Changes

Related Party Transactions

• The document describes related party transactions including the Definitive OpCo Amended LLC Agreement, Tax Receivable Agreement, Nominating Agreements, and Registration Rights Agreement.

Stakeholder Impact

• Shareholders are asked to vote on key proposals that will impact the company's governance and executive compensation.
• Employees are affected by the company's compensation policies and benefit plans.
• Customers benefit from the company's efforts to improve its products and services.
• The company's financial performance impacts its suppliers and creditors.

Next Steps

• Stockholders are encouraged to vote on the proposals outlined in the Proxy Statement.
• The Board of Directors will consider the results of the advisory vote on executive compensation when making future compensation decisions.
• The company will continue to execute its strategic plan to drive long-term growth and value creation.

Key Dates

Keywords

Annual Meeting, Proxy Statement, Board of Directors, Executive Compensation, Director Election, Deloitte & Touche, Stockholders, Governance, Definitive Healthcare